Science.Online
Publisher and Institutes
Akademie Verlag
Deutsches Institut für Urbanistik
Oldenbourg Wissenschaftsverlag
Walter de Gruyter
Schattauer
You are here: Home :: Area NEM :: Medical science :: Human medicine
 
Einor Ben Assayag, Irena Bova, Shlomo Berliner, Hava Peretz, Sali Usher, Itzhak Shapira, Natan M. Bornstein

Gender differences in the expression of erythrocyte aggregation in relation to B-fibrinogen gene polymorphisms in apparently healthy individuals

Keywords: Erythrocyte aggregation, fibrinogen, gene polymorphism

An increased erythrocyte aggregation (EA) is associated with capillary slow flow, tissue hypoxemia and endothelial dysfunction. Fibrinogen is a major determinant in the formation of aggregated red blood cells. It has been suggested that the B-fibrinogen 455G/A polymorphism is associated with erythrocyte hyperaggregability in men with coronary artery disease. The purpose of this study was to investigate the influence of the -fibrinogen 455G/A polymorphism on erythrocyte aggregation in apparently healthy individuals. Plasma fibrinogen, red blood cell count, serum lipids, erythrocyte sedimentation rate, and the genotype of the B-fibrinogen 455G/A polymorphism were examined in a cohort of 545 apparently healthy individuals and those with atherothrombotic risk factors. A whole blood erythrocyte aggregation test was performed by using a simple slide test and image analysis. In men, EA levels and plasma fibrinogen levels were significantly higher in subjects carrying the 455A allele compared to subjects with the 455 GG genotype. This association did not exist in women carrying the fibrinogen 455A allele. The 455GA/AA men presented significantly higher correlation between the plasma fibrinogen concentrations and EA. This observation raises the prospect of possible change in the functional properties of the 455GA/AA fibrinogen, enhancing its ability to induce EH. This study suggests that the B-fibrinogen 455A allele is related to EH in men only. Putative mechanism could be hyperfibrinogenemia and a functional change in the fibrinogen molecule that alters its ability to interact with red blood cells and supports the aggregability of these cells.

Thrombosis and Haemostasis, Schattauer

Print ISSN: 0340-6245
Volume: 95, 03/2006
Pages: 428 - 433

Show full article (external site)

Show all available items of this journal